scholarly journals Versatile DNA damage detection by the global genome nucleotide excision repair protein XPC

2008 ◽  
Vol 121 (17) ◽  
pp. 2972-2972
Author(s):  
D. Hoogstraten ◽  
S. Bergink ◽  
V. H. M. Verbiest ◽  
M. S. Luijsterburg ◽  
B. Geverts ◽  
...  
2008 ◽  
Vol 121 (17) ◽  
pp. 2850-2859 ◽  
Author(s):  
D. Hoogstraten ◽  
S. Bergink ◽  
J. M. Y. Ng ◽  
V. H. M. Verbiest ◽  
M. S. Luijsterburg ◽  
...  

2008 ◽  
Vol 121 (23) ◽  
pp. 3991-3991 ◽  
Author(s):  
D. Hoogstraten ◽  
S. Bergink ◽  
J. M. Y. Ng ◽  
V. H. M. Verbiest ◽  
M. S. Luijsterburg ◽  
...  

2014 ◽  
Vol 106 (2) ◽  
pp. 690a
Author(s):  
Yogambigai Velmurugu ◽  
Xuejing Chen ◽  
Jung-Hyun Min ◽  
Anjum Ansari

Nature ◽  
2007 ◽  
Vol 449 (7162) ◽  
pp. 570-575 ◽  
Author(s):  
Jung-Hyun Min ◽  
Nikola P. Pavletich

2019 ◽  
Vol 2019 ◽  
pp. 1-8
Author(s):  
Joseph W. George ◽  
Mika Bessho ◽  
Tadayoshi Bessho

Gemcitabine (2′, 2′-difluorodeoxycytidine; dFdC) is a deoxycytidine analog and is used primarily against pancreatic cancer. The cytotoxicity of gemcitabine is due to the inhibition of DNA replication. However, a mechanism of removal of the incorporated dFdC is largely unknown. In this report, we discovered that nucleotide excision repair protein XPF-ERCC1 participates in the repair of gemcitabine-induced DNA damage and inactivation of XPF sensitizes cells to gemcitabine. Further analysis identified that XPF-ERCC1 functions together with apurinic/apyrimidinic endonuclease (APE) in the repair of gemcitabine-induced DNA damage. Our results demonstrate the importance of the evaluation of DNA repair activities in gemcitabine treatment.


2011 ◽  
Vol 18 (2) ◽  
pp. 191-197 ◽  
Author(s):  
Marcin Jaciuk ◽  
Elżbieta Nowak ◽  
Krzysztof Skowronek ◽  
Anna Tańska ◽  
Marcin Nowotny

Sign in / Sign up

Export Citation Format

Share Document